Skip to content

DentalPharma: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DentalPharma

BE 0477.269.296
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€56,969
2024 · €32,468+€24,501
Equity
€72,964
2024 · €15,995+€56,969
Cash
€25,741
2024 · €18,790+€6,950
Balance sheet total
€228,805
2024 · €168,053+€60,752

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€29,376

    up €29,376 (+67.3%), from €43,662 to €73,038

    of which Trade receivables: +€28,313

  • Stocks and contracts +€20,643

    up €20,643 (+23.3%), from €88,420 to €109,063

  • Cash +€6,950

    up €6,950 (+37.0%), from €18,790 to €25,741

    mainly Net result for the year (+€56,969) and Tax, wage and social debts (+€10,296)

  • Deferred charges and accrued income +€2,492

    up €2,492 (+61.0%), from €4,083 to €6,575

Equity and liabilities
  • Reserves +€52,339

    up €52,339 (+2,791%), from €1,875 to €54,214

    of which Distributable reserves: +€52,339

  • Tax, wage and social debts +€10,296

    up €10,296 (+497%), from €2,070 to €12,365

  • Debts after one year -€8,140

    down €8,140 (-10.8%), from €75,373 to €67,233

  • Trade debts +€6,937

    up €6,937 (+21.6%), from €32,115 to €39,052

  • Short-term financial debts -€6,500

    down €6,500 (-15.3%), from €42,500 to €36,000

Income statement
  • Gross operating margin +€33,132

    up €33,132 (+78.1%), from €42,448 to €75,580

  • Taxes +€16,615

    up €16,615 (+699%), from €2,378 to €18,993

  • Financial income +€7,711

    up €7,711 (+1,654%), from €466 to €8,177

  • Financial charges -€1,151

    down €1,151 (-19.6%), from €5,860 to €4,710

  • Other operating charges +€1,049

    up €1,049 (+271%), from €387 to €1,436

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €32,468
Gross operating margin +€33,132
Depreciation +€170
Other operating charges -€1,049
Financial income +€7,711
Financial charges +€1,151
Taxes -€16,615
Result 2025 €56,969
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€24,531
Investment -€2,941
Financing -€14,640
Cash 2024 €18,790
Net result for the year +€56,969
Depreciation +€1,650
Stocks and contracts -€20,643
Receivables within one year -€29,376
Deferred charges and accrued income -€2,492
Trade debts +€6,937
Tax, wage and social debts +€10,296
Accrued charges and deferred income +€1,190
Investment in fixed assets (net) -€2,941
Debts after one year -€8,140
Short-term financial debts -€6,500
Cash 2025 €25,741
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €168,053 €228,805 +€60,752 +36.2%
Fixed assets 21/28 €13,097 €14,389 +€1,292 +9.9%
Tangible fixed assets 22/27 €13,097 €14,389 +€1,292 +9.9%
Land and buildings 22 €12,950 €11,816 -€1,134 -8.8%
Plant, machinery and equipment 23 - €1,460 +€1,460
Furniture and vehicles 24 €147 €1,113 +€966 +655%
Current assets 29/58 €154,956 €214,416 +€59,461 +38.4%
Stocks and contracts in progress 3 €88,420 €109,063 +€20,643 +23.3%
Stocks 30/36 €88,420 €109,063 +€20,643 +23.3%
Amounts receivable within one year 40/41 €43,662 €73,038 +€29,376 +67.3%
Trade receivables 40 €31,033 €59,346 +€28,313 +91.2%
Other amounts receivable 41 €12,629 €13,692 +€1,063 +8.4%
Cash at bank and in hand 54/58 €18,790 €25,741 +€6,950 +37.0%
Deferred charges and accrued income 490/1 €4,083 €6,575 +€2,492 +61.0%
Total equity and liabilities 10/49 €168,053 €228,805 +€60,752 +36.2%
Equity 10/15 €15,995 €72,964 +€56,969 +356%
Contributions 10/11 €18,750 €18,750 = 0.0%
Reserves 13 €1,875 €54,214 +€52,339 +2,791%
Non-distributable reserves 130/1 €1,875 €1,875 = 0.0%
Reserves not available under the articles 1311 €1,875 €1,875 = 0.0%
Distributable reserves 133 - €52,339 +€52,339
Profit (loss) carried forward 14 -€4,630 - +€4,630
Amounts payable 17/49 €152,058 €155,841 +€3,783 +2.5%
Amounts payable after more than one year 17 €75,373 €67,233 -€8,140 -10.8%
Financial debts 170/4 €75,373 €67,233 -€8,140 -10.8%
Amounts payable within one year 42/48 €76,684 €87,417 +€10,733 +14.0%
Financial debts 43 €42,500 €36,000 -€6,500 -15.3%
Credit institutions 430/8 €42,500 €36,000 -€6,500 -15.3%
Trade debts 44 €32,115 €39,052 +€6,937 +21.6%
Suppliers 440/4 €32,115 €39,052 +€6,937 +21.6%
Taxes, remuneration and social security 45 €2,070 €12,365 +€10,296 +497%
Taxes 450/3 €2,070 €12,365 +€10,296 +497%
Accrued charges and deferred income 492/3 - €1,190 +€1,190
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,820 €1,650 -€170 -9.3%
Other operating charges 640/8 €387 €1,436 +€1,049 +271%
Gross operating margin 9900 €42,448 €75,580 +€33,132 +78.1%
Operating profit (loss) 9901 €40,241 €72,494 +€32,253 +80.2%
Financial income 75/76B €466 €8,177 +€7,711 +1,654%
Recurring financial income 75 €466 €8,177 +€7,711 +1,654%
Financial charges 65/66B €5,860 €4,710 -€1,151 -19.6%
Recurring financial charges 65 €5,860 €4,710 -€1,151 -19.6%
Profit (loss) for the period before taxes 9903 €34,847 €75,962 +€41,115 +118%
Income taxes 67/77 €2,378 €18,993 +€16,615 +699%
Profit (loss) for the period 9904 €32,468 €56,969 +€24,501 +75.5%
Profit (loss) for the period to be appropriated 9905 €32,468 €56,969 +€24,501 +75.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.